Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

This Morning presenter Ruth Langsford has opened up about her recent weight loss and shared the heartbreaking reason she has ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...

This Morning presenter Ruth Langsford has opened up about her recent weight loss, saying that she thinks her divorce from ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, potentially paving the way for broader treatments.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...